T1	CHEM 62 84	fármacos anti-demencia
#1	AnnotatorNotes T1	C3653789; ANTI-DEMENTIA DRUGS; Pharmacologic Substance
T2	DISO 76 84	demencia
#2	AnnotatorNotes T2	C0497327; Dementia; Mental or Behavioral Dysfunction
T3	DISO 88 96	demencia
#3	AnnotatorNotes T3	C0497327; Dementia; Mental or Behavioral Dysfunction
T4	PROC 129 199	Ensayo clínico, pragmático, abierto con evaluador cegado, aleatorizado
T5	PROC 205 224	evaluar la eficacia
#4	AnnotatorNotes T5	C1707887; Efficacy Study; Research Activity
T6	PROC 240 265	tratamiento farmacológico
#5	AnnotatorNotes T6	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T7	DISO 283 291	demencia
#6	AnnotatorNotes T7	C0497327; Dementia; Mental or Behavioral Dysfunction
T8	DISO 324 332	Demencia
#7	AnnotatorNotes T8	C0497327; Dementia; Mental or Behavioral Dysfunction
T9	DISO 383 385	EA
#8	AnnotatorNotes T9	C0002395; Alzheimer's Disease; Disease or Syndrome
T10	DISO 387 427	DV (subcortical de pequeño vaso) o mixta
T11	ANAT 391 402	subcortical
#9	AnnotatorNotes T11	C0815275; Subcortical; Body Location or Region
T12	ANAT 414 418	vaso
#10	AnnotatorNotes T12	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C0042591; Vessel Positions; Body Location or Region
T13	DISO 480 488	Demencia
#11	AnnotatorNotes T13	C0497327; Dementia; Mental or Behavioral Dysfunction
T14	PROC 511 522	Tratamiento
#12	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	DISO 544 552	demencia
#13	AnnotatorNotes T15	C0497327; Dementia; Mental or Behavioral Dysfunction
T16	CHEM 563 572	memantina
#14	AnnotatorNotes T16	C0025242; memantine; Organic Chemical · Pharmacologic Substance
T17	DISO 659 667	demencia
#15	AnnotatorNotes T17	C0497327; Dementia; Mental or Behavioral Dysfunction
T18	PROC 728 739	seguimiento
#16	AnnotatorNotes T18	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T19	CHEM 527 552	fármacos para la demencia
T20	PROC 499 503	MMSE
#17	AnnotatorNotes T20	C0451306; Mini-mental state examination; Diagnostic Procedure
T21	CHEM 554 558	IACh
#18	AnnotatorNotes T21	C0001046; Acetylcholinesterase Inhibitors; Pharmacologic Substance
T22	Date 13 17	2017
T23	LIVB 269 278	pacientes
#19	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	LIVB 370 378	Paciente
#20	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T26	Duration 574 602	al menos los 3 meses previos
T27	LIVB 631 640	Pacientes
#21	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 680 689	Pacientes
#22	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T25	LIVB 447 456	neurólogo
#23	AnnotatorNotes T25	C0237426; Neurologist; Professional or Occupational Group
T29	LIVB 459 476	médico de familia
#24	AnnotatorNotes T29	C1704221; Physicians, Family; Professional or Occupational Group
#25	AnnotatorNotes T4	C4684737; Pragmatic Trial; Research Activity + C0150108; Blinded; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity + C1709323; Open Label Study; Research Activity 
T30	CONC 698 715	esperanza de vida
#26	AnnotatorNotes T30	C0023671; Life Expectancy; Group Attribute
T31	Result_or_Value 716 739	inferior al seguimiento
R1	Has_Result_or_Value Arg1:T30 Arg2:T31	
T32	Quantifier_or_Qualifier 97 105	avanzada
R2	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T32	
R3	Experiences Arg1:T23 Arg2:T7	
R4	Experiences Arg1:T23 Arg2:T6	
T33	Quantifier_or_Qualifier 292 300	avanzada
R5	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T33	
T34	Quantifier_or_Qualifier 333 341	avanzada
R6	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T34	
R7	Experiences Arg1:T24 Arg2:T9	
R8	Experiences Arg1:T24 Arg2:T10	
R9	Location_of Arg1:T11 Arg2:T10	
R10	Location_of Arg1:T12 Arg2:T10	
T35	Result_or_Value 504 507	≤10
R11	Has_Result_or_Value Arg1:T20 Arg2:T35	
T36	Quantifier_or_Qualifier 489 497	avanzada
R12	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T36	
R13	Used_for Arg1:T19 Arg2:T14	
R14	Used_for Arg1:T21 Arg2:T14	
R15	Used_for Arg1:T16 Arg2:T14	
R16	Has_Duration_or_Interval Arg1:T16 Arg2:T26	
R17	Has_Duration_or_Interval Arg1:T21 Arg2:T26	
R18	Has_Duration_or_Interval Arg1:T19 Arg2:T26	
R19	Experiences Arg1:T27 Arg2:T17	
T37	Quantifier_or_Qualifier 668 676	avanzada
T38	Quantifier_or_Qualifier 646 658	otro tipo de
R20	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T38	
R21	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T37	
#27	AnnotatorNotes T34	C0205179; Advanced phase; Qualitative Concept
#28	AnnotatorNotes T36	C0205179; Advanced phase; Qualitative Concept
#29	AnnotatorNotes T37	C0205179; Advanced phase; Qualitative Concept
#30	AnnotatorNotes T33	C0205179; Advanced phase; Qualitative Concept
#31	AnnotatorNotes T32	C0205179; Advanced phase; Qualitative Concept
#32	AnnotatorNotes T19	C3653789; ANTI-DEMENTIA DRUGS; Pharmacologic Substance
A1	Experiencer T23 Patient
A2	Experiencer T24 Patient
A3	Experiencer T25 Other
A4	Experiencer T29 Other
A5	Experiencer T27 Patient
A6	Experiencer T28 Patient
